Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia

BACKGROUND: Hypertriglyceridemia is associated with increased cardiovascular risk and may be caused by impaired lipoprotein clearance. Angiopoietin-like protein 3 (ANGPTL3) inhibits lipoprotein lipase activity, increasing triglycerides and other lipids. Evinacumab, an ANGPTL3 inhibitor, reduced trig...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Zahid, Banerjee, Poulabi, Hamon, Sara, Chan, Kuo-Chen, Bouzelmat, Aurelie, Sasiela, William J., Pordy, Robert, Mellis, Scott, Dansky, Hayes, Gipe, Daniel A., Dunbar, Richard L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686956/
https://www.ncbi.nlm.nih.gov/pubmed/31242752
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.039107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686956/
https://www.ncbi.nlm.nih.gov/pubmed/31242752
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.039107

Ejemplares similares